STOCK TITAN

Marex Group plc SEC Filings

MRX NASDAQ

Welcome to our dedicated page for Marex Group plc SEC filings (Ticker: MRX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

This page compiles U.S. Securities and Exchange Commission filings for Marex Group plc (NASDAQ: MRX), a diversified global financial services platform operating across energy, commodities and financial markets. As a foreign private issuer, Marex files an annual report on Form 20-F and periodic Form 6-K reports that furnish press releases and financial information to U.S. investors.

Recent Form 6-K filings include earnings-related disclosures, such as interim results, third quarter results and preliminary trading updates. These documents provide detail on revenue, adjusted profit before tax, segment performance across Clearing, Agency and Execution, Market Making, and Hedging and Investment Solutions, as well as information on net commission income, net trading income, net interest income and net physical commodities income. They also discuss non-IFRS measures, their definitions and reconciliations to the most comparable IFRS metrics.

Other 6-Ks relate to corporate actions and governance, including press releases about purchases of ordinary shares by the Chief Executive Officer and other directors and officers. These filings help investors track insider share dealings and understand how management and board members are building or adjusting their holdings in Marex.

Filings may also reference capital and ratings developments, such as senior debt issuances, Additional Tier 1 instruments and credit ratings from S&P Global Ratings for Marex Group and its U.S. subsidiary, Marex Capital Markets Inc. Together, these disclosures provide insight into the Group’s capital structure, funding and external credit assessment.

On Stock Titan, Marex’s SEC filings are updated as new documents are released on EDGAR. AI-powered tools can assist users by surfacing key points from lengthy filings, highlighting segment trends, explaining non-IFRS measures and drawing attention to notable items such as insider transactions and earnings commentary, helping readers navigate the technical language common in cross-border capital markets reporting.

Rhea-AI Summary

FMR LLC reports beneficial ownership of 3,724,911 shares of Marex Group PLC common stock, equal to 5.1% of the class as of 03/31/2026. The filing states FMR LLC holds sole dispositive power over 3,724,911 shares and sole voting power of 3,720,946 shares; Abigail P. Johnson is identified with dispositive authority.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.9%
Tags
ownership
-
Rhea-AI Summary

Marex Group plc delivered a record first quarter 2026, with revenue of $692.3m, up 48% year on year, driven by strong client activity and elevated market volatility across all segments.

Profit before tax from continuing operations rose to $149.8m, a 53% increase, while profit after tax from continuing operations reached $112.3m, up 55%. Basic EPS grew to $1.52 from $0.98, and adjusted profit before tax climbed 59% to $152.7m, lifting the adjusted profit before tax margin to 22.1%.

Return on equity improved to 34.4%, with adjusted return on equity at 37.4%. The Board approved a higher dividend of $0.16 per share, payable on June 3, 2026. Total assets increased to $36.5bn and total available liquid resources were $3.0bn, while the total capital ratio strengthened to 253%, indicating substantial capital headroom.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.9%
Tags
current report
-
Rhea-AI Summary

Marex Group plc Group Head of Clearing Thomas Texier sold a total of 14,427 Ordinary Shares in open-market transactions. The sales on May 1, 2026 were executed at weighted average prices of $52.8713 and $53.5287 per share under a pre-arranged Rule 10b5-1 plan.

Following these transactions, Texier directly owns 228,231 Ordinary Shares, which the disclosure states includes 192,348 shares underlying previously granted deferred bonus plan awards that settle into one ordinary share each upon vesting.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Marex Group plc is offering Autocallable Leveraged Barrier Notes linked to the worst performing of the iShares Silver Trust (SLV) and the VanEck Gold Miners ETF (GDX).

Each Note has a $1,000 principal amount, an Upside Participation Rate of 300%, a Barrier Percentage of -30%, an illustrative Call Premium of at least 22% if automatically called, and a maturity date of June 1, 2029. The Trade Date and Pricing Date are May 29, 2026 with Original Issue Date of June 3, 2026. The Estimated Initial Value is expected to be between $930.00 and $980.00 per Note, which is stated to be less than the price to public. The Notes do not pay interest, are senior unsecured obligations of Marex, and are subject to Marex credit risk and market exposure to the Worst Performing Underlying.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

Marex Group plc is offering Capped Leveraged Buffered Notes linked to the worst performing of the EURO STOXX 50® (SX5E) and the iShares MSCI EAFE ETF (EFA), with an Original Issue Date of June 3, 2026 and a Maturity Date of December 2, 2027. The Notes pay no interest and will pay a cash Payment at Maturity based on the Reference Return of the Worst Performing Underlying measured between the Pricing Date and the Final Valuation Date (November 29, 2027).

The economic terms shown in the pricing supplement include a Principal Amount of $1,000 per Note, an Upside Participation Rate of 200.00%, a Maximum Return of at least 28.00%, and a Buffer Percentage of -10.00% (Buffer Amount 10.00%). The Estimated Initial Value on the Pricing Date is expected to be between $950.00 and $990.00 per Note. These are senior unsecured obligations of Marex and are subject to Marex's credit risk, limited liquidity, exchange‑rate and foreign‑market risks, and the structural caps and buffers described above.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

Marex Group plc is offering Autocallable Contingent Income Barrier Notes linked to the worst performing of the S&P 500, Russell 2000 and Nasdaq-100. The notes have a $1,000 principal amount per note, may pay a quarterly contingent coupon (at least 2.75% per quarter; 11.00% per annum), are callable if each underlying is at or above 100% of its initial value on a Call Observation Date, and mature on June 1, 2029 (Final Valuation Date: May 29, 2029). If the Worst Performing Underlying’s Reference Return is below -30.00% at maturity, investors suffer full downside exposure and may lose up to 100% of principal; Coupons are paid only when each underlying is at or above 70.00% of its initial value on the relevant determination dates. Estimated initial value on the Pricing Date is expected between $950.00 and $990.00 per note.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
Rhea-AI Summary

Marex Group plc is offering Contingent Income Barrier Notes linked to the worst performing of DIA, QQQ and SPY, with a $1,000 principal per note and an expected term of approximately three years to May 24, 2029. Monthly contingent coupons will be payable at a rate of at least 0.758% per month (approximately 9.10% per annum) if each underlying closes at or above 70.00% of its initial value on the coupon determination date. If the worst performing underlying declines by more than 30.00% at final valuation, principal is exposed to loss on a 1:1 basis. The Estimated Initial Value is expected to be between $955.00 and $995.00 per note and will be set on the Trade Date.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus
-
Rhea-AI Summary

MRX reported proposed resale of 15,999 shares of Common Stock via a Form 144 filing. The filing lists recent dispositions by Thomas Texier: 14,427 shares sold on 02/02/2026 ($567,398.04), 03/02/2026 ($633,750.70), and 04/01/2026 ($627,715.88). The securities to be sold were acquired in a private transaction on 02/26/2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Rhea-AI Summary

Marex Group plc is offering $8,500,000 of Issuer Callable Contingent Income Barrier Notes linked to the worst performing of the iShares MSCI EAFE ETF, the Russell 2000 and the Nasdaq-100. The Notes pay a quarterly Contingent Coupon of $34.75 per $1,000 (3.475% per quarter; 13.90% per annum) only if each underlying meets its Coupon Trigger on scheduled Coupon Determination Dates. The Notes mature on January 27, 2028 (Final Valuation Date January 24, 2028) and are issuer‑callable on specified quarterly Call Payment Dates beginning July 28, 2026. At maturity you may receive the Principal plus final Contingent Coupon, the Principal only, or suffer up to 100% principal loss if the Worst Performing Underlying falls below its Barrier Value.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.64%
Tags
prospectus
Rhea-AI Summary

Marex Group plc is offering Issuer Callable Contingent Income Barrier Notes linked to the worst performing of the EFA, RTY and NDX. The Notes have a $1,000 Principal Amount per Note, a Trade Date of April 24, 2026, an Original Issue Date of April 29, 2026, a Final Valuation Date of January 24, 2028 and a Maturity Date of January 27, 2028.

The Notes pay a quarterly Contingent Coupon of $34.75 per $1,000 (3.475% per quarter; 13.90% per annum) only if each Underlying is at or above its Coupon Trigger on the applicable Coupon Determination Date; otherwise no coupon is paid. The Coupon Trigger equals 70% of the Initial Value and the Barrier Value equals 65% of the Initial Value. Payment at maturity depends on the Reference Return of the Worst Performing Underlying with principal fully at risk if the Final Value is below the Barrier Value.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
prospectus

FAQ

How many Marex Group plc (MRX) SEC filings are available on StockTitan?

StockTitan tracks 101 SEC filings for Marex Group plc (MRX), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for Marex Group plc (MRX)?

The most recent SEC filing for Marex Group plc (MRX) was filed on May 6, 2026.